Found 99 matching trials
A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months PHASE3 This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Show More Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) PHASE3 This study will determine whether participants who receive the vaccine V419...
Show More Location
Multiple Locations
Learn More & Join Trial
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) PHASE3 To evaluate the immune response and the safety of a primary series schedule...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children PHASE3 This study will be conducted in two stages. In the diphtheria, tetanus, per...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Conjugate Vaccine Against Meningococcus C a Brazilian Project PHASE2 TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blin...
Show More Location
• Unidade de Ensaios Clínicos para Imunobiológicos/Instituto de Tecnologia em Imunobiológicos de Bio-Manguinhos/Fiocruz
Learn More & Join Trial
A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years PHASE3 This is a multicenter, randomized, double-blinded, positive controlled stud...
Show More Location
Husada Utama Hospital
Learn More & Join Trial
Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III) PHASE3 This is a multicenter, randomized, observer-blinded, controlled, immune equ...
Show More Location
Lingga Health Research Center
Learn More & Join Trial
Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine PHASE3 Infants aged 9 months will be randomized to receive a meningococcal vaccine...
Show More Location
Centre pour le Developpement des Vaccins du Mali
Learn More & Join Trial
Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents PHASE2 This study was designed to evaluate the antibody response to a Menactra® bo...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunology and Safety of Menactra® in Children in Saudi Arabia PHASE3 This study will be conducted among children in Saudi Arabia who previously ...
Show More Location
Multiple Locations
Learn More & Join Trial